Research by Shibori Watanabe et al. (2021) examines the antidiabetic influence of bioactive compounds found in Moringa Oleifera, based on 44 studies involving diabetic rodents. The presence of phytochemicals such as quercetin, chlorogenic acid, and various flavonoids is highlighted. These substances are shown to boost insulin secretion, enhance glucose tolerance, and decrease intestinal glucose absorption, leading to lower blood sugar levels. This study underscores Moringa Oleifera's comprehensive approach to diabetes management by addressing blood sugar control and reducing oxidative stress and inflammation, which are prevalent complications in diabetes patients.

Xinyue Su et al. (2023) review studies on the active components and applications of Moringa Oleifera, attributing its antidiabetic effects to its ability to regulate glucose and lipid metabolism. This includes polyphenols and flavonoids, which improve insulin sensitivity and safeguard pancreatic β-cells against dysfunction and cell death, aiding in glucose balance.

The work of Stohs and Hartman (2015) sheds light on the antidiabetic benefits of Moringa Oleifera, emphasizing its effectiveness in reducing blood glucose levels and bettering lipid profiles. Lipid profiles, which are assessments of various fats in the blood, help gauge the risk of cardiovascular diseases and diabetes. Although limited human studies exist, the potential of Moringa Oleifera in treating hyperglycemia and dyslipidemia is evident, with support from animal studies that affirm its wide-ranging benefits, including anti-inflammatory, antihypertensive, and tissue-protective properties.

Analysis by Ashutosh Pareek et al. (2023) on global research regarding Moringa Oleifera indicates its myriad benefits, including antidiabetic properties. The study reveals that Moringa leaf extracts can decrease fasting glucose, hemoglobin, LDL, and VLDL levels in type 2 diabetic patients. A preclinical trial demonstrated the antidiabetic effect of the aqueous extract by controlling blood glucose, protein, sugar, and hemoglobin levels.

A study by Gómez-Martínez et al. (2021) explores the impact of Moringa Oleifera leaf supplementation in prediabetes cases. Participants were given dry Moringa leaf powder or a placebo over 12 weeks. The findings reveal notable improvements in fasting blood glucose and glycated hemoglobin levels in the Moringa group versus the placebo, highlighting its potential as an effective natural antihyperglycemic agent. Additionally, no adverse effects from the supplementation were observed.

Michał Krawczyk et al. (2022) conduct a meta-analysis on Polyphenol in Gymnema montanum, Momordica charantia, and Moringa Oleifera. Laboratory and cellular studies indicate that Moringa extracts contain significant polyphenol concentrations, particularly flavonoids and phenolic acids. Additionally, a human study revealed that participants who ingested Moringa leaf (8 g) for 40 days experienced substantial reductions in fasting (28%) and postprandial (26%) blood glucose levels, underscoring the antidiabetic potential of Moringa Oleifera through its antioxidant properties that aid in glucose reduction.